Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells
Kumiko Oida(Tokyo University of Agriculture and Technology), Akane Tanaka(Tokyo University of Agriculture and Technology)
Cited by 57
Related Papers
A New IκB Kinase β Inhibitor Prevents Human Breast Cancer Progression through Negative Regulation of Cell Cycle Transition
|Cancer Research|2006|56
A point mutation in the extracellular domain of KIT promotes tumorigenesis of mastcells via ligand-independent auto-dimerization
|Scientific Reports|2015|14